Emergent BioSolutions (EBS) EPS (Diluted) (2011 - 2026)
Emergent BioSolutions (EBS) EPS (Diluted) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.27 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.39 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -3.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.49 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | -0.96 |
| Sep 30, 2025 | 0.91 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | 1.19 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | 2.06 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | -0.97 |
| Sep 30, 2023 | -5.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -3.71 |
| Dec 31, 2022 | -1.34 |
| Sep 30, 2022 | -1.75 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | 3.29 |
| Sep 30, 2021 | -0.61 |